Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Nova Stream

 

Aino Health enters roll-out phase in Europe and the Gulf states

Finnish preventive care group Aino Health Management Oy is entering an aggressive roll-out phase by expanding in Europe and the Middle East. Already in Finland, Sweden, Germany and the UAE, it is in talks to enter Saudi Arabia as part of a $54m deal –and potentially the UK in 2017.

Healthcare Nova March 2016

Healthcare Nova March 2016 We delve into the debate on the price of private healthcare in South Africa, get the inside scoop on Stuart Fletcher's removal from Bupa and examine the potential of rating and booking sites in Emerging Markets.    

Rating and booking sites: Threats or Friends?

There are growing signs that a new generation of rating and booking websites will change the face of outpatient care in many Emerging Markets. New players, sometimes backed by hundreds of millions of dollars, are investing in telehealth platforms that promise instant access to patients, partnering with pharmacies and making access to healthcare easier for patients. Some are active in dozens of countries. Here we talk to the major players about their strategies and how they see the market.

Siloam to invest $100m in expansion

Indonesia's largest hospital group PT Siloam International has a two-year plan to expand regionally with 13 new emergency hospitals. We talk to Managing Director Dr. Grace Frelita about the challenges faced by healthcare in the country.

KPJ seeks Malaysian dominance

Malaysia’s biggest hospital group KPJ Healthcare Berhad will spend RM1.3bn (US$333m) on eight new hospitals and RM4-500m (US$100-128m) on expansions to seven existing hospitals over the next three to five years. In 2012, the group announced aggressive plans to reach 40 hospitals by 2020 and with 25 already it’s well placed to dominate a prosperous market, Inani Rozidin, an analyst at Alliance DBS, tells us.

Apollo Sugar to open 30 clinics this year

The specialist Indian diabetes group, Apollo Sugar, plans to open 30 new clinics in five cities this fiscal year. The JV between Apollo Hospitals and pharma giant Sanofi is moving into second-tier Indian cities by opening smaller clinics funded by internal accruals and spare capital. “This model is more capital efficient,” CEO Gagan Bhalla told the local press.

Contrasting healthcare markets in the GCC

Too reliant on revenues from the petroleum industry, the GCC countries are pushing for economic diversification – and competing for foreign investment. As a result, the healthcare industry is seeing major government incentives and huge PPP projects. We look at how Saudi Arabia, the UAE and smaller Gulf states are drawing investors.

Abraaj close to $1bn target

Abraaj is close to its $1bn target for its mammoth Global Healthcare Fund. And its ambitions are becoming clearer.

So what really happened at Bupa?

After four years, in which he transformed Bupa with a £1.8bn M&A drive, the company announced that CEO Stuart Fletcher is to leave after failing to meet expectations. His departure follows 2015 results which saw a fall of pre-tax profits of 39% to £347m. Where does that leave his plans to build an international brand with strengths in services as well as insurance? What really went wrong? With 2015 sales of £9.8bn, Bupa still has heft. Outside the USA, it remains one of the two largest international private medical insurers, the largest international dentistry player, one of the largest care home groups and, probably, the largest player in outpatient care – certainly the only one with scale in four continents.

Find Us